# Schulze Muscular Dystrophy Ability Clinical Study

> **NCT05409079** · NA · UNKNOWN · sponsor: **AbiliTech Medical Inc.** · enrollment: 35 (estimated)

## Conditions studied

- Muscular Dystrophies
- Spinal Muscular Atrophy
- Duchenne Muscular Dystrophy
- Limb Girdle Muscular Dystrophy
- FSHD
- Cerebral Palsy
- Becker Muscular Dystrophy

## Interventions

- **DEVICE:** Abilitech Assist

## Key facts

- **NCT ID:** NCT05409079
- **Lead sponsor:** AbiliTech Medical Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-26
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2022-12-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05409079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05409079, "Schulze Muscular Dystrophy Ability Clinical Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05409079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*